Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RNVA news IS FOXO news. FOXO principals turning over the company and patents to RNVA for a small percentage of the whole (Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and the existing FOXO Technologies, Inc.).
December 12 is still the hard deadline. The release said the NYSE American accepted the plan which would have included shopping the MA that RNVA would eventually enter into. The RNVA deal is the ticket to compliance. RNVA proxy material including financials coming any day now.
Never mind. You have me doing it now. The news release you posted was from 7/31 last year.
Jay, do you misread stuff on purpose? The NYSE American accepted the FOXO compliance plan. In other words, the exchange thinks the plan should support a higher stock price without a reverse split. Of course, we all know the plan involves the share exchange agreement with RNVA. FOXO must be in compliance by December 12.
Two days in a row you have posted something that twists good news into bad.
Jay, you should be concluding just the opposite. The FOXO principals took common shares. Class A preferred shares will belong to RNVA. The worst outcome if the NYSE AMEX SLAP is not approved is that RNVA moves on with an audited 2023 10-K and current 10-Qs, probably with accelerated completion of corporate equity buybacks.
Dingbatt, you need to start thinking for yourself. Based on your ideology, RNVA should be the last stock you would ever choose.
A PE of 20 (.0024 in RNVA shares) would be reasonable.
Completion of the RNVA deal means listing compliance, FOXO can't comply without it.
Yes sir. Very interesting FOXO filings after market close yesterday. Clearing the way for RNVA!
Secretariat never had to come from the back of the pack. He was usually running away from the field halfway down the stretch.
No doubt that prospectus is being/has been renegotiated and the insider trading plan will be amended accordingly. I'm guessing the buybacks will be completed for some while others hold for FOXO Class A preferred shares. Just guessing though.
That's not to say we might not see a 10-K and 10-Q filed first, as in days or hours before the proxy materials are filed, or possibly days or hours after, or possibly all at one time. Point is, we'll find out any day now.
FOXO end approved 7/17. Proxy material on the RNVA end should be issued any day now. When that happens we know it's a done deal because the CEO has the proxy on a majority of the votes. Also, rest assured, the CEO will have dotted the i's and crossed the t's with the regulators. We will also get a better idea when the green light on trading will come. That will be one hell of a green light.
FOXO had been shopping a M/A for a long time, previous attempts fell through. That history is in the FOXO 10-K.
It appears the FOXO deal was already in the works when the 10-K deadline was approaching, so I don't think it was as much foot-dragging as it was a matter of sequencing and efficiency of the effort. But, you are right, it's a pretty extensive and complicated undertaking.
Lawyers, accountants, and regulators at work. Insider holdings being consolidated. Whatever the proxy materials (RNVA financial statements and plan for FOXO) say will have already been discussed with SEC and exchange regulators.
I don't see any way RNVA shareholder could be "left behind." We will own what the CEO and BoD will own.
RNVA is getting $20 million of overwhelming controlling equity in FOXO plus financing ($2.5 million) and common shares ($500,000) equal to FOXO's current market cap. That means RNVA earnings ($5.2 million p/y and growing) will be unimpaired by costs to commercialize the seven FOXO patents RNVA will own. RNVA gets FOXO for the cost of the paperwork. Damned right, gotta love it.
That seems pretty likely, but hard to say for sure at least until the proxy material is filed. A few steps to go before RNVA takes over FOXO. I'm sure the CEO is taking pains as we speak to make sure the RNVA financial statements and plan for FOXO meet SEC requirements for a NYSE AM listing. That is the FOXO supplemental listing application (SLAP) that will bring that listing into compliance. I would think RNVA filings can and will be brought current in the meantime, but maybe it all happen turnkey, much quicker than that. We'll all know a lot more soon.
I vaguely recall a conversation I had with someone at TD Ameritrade when EM first became a thing, because I held some shares in a company that had previously gone dark and was later designated EM. You could still get L2 quotes on dark companies before then, and I had actually successfully traded the position that way. All I remember is that I could continue trading it but had to call the order in. I've placed GTC sell orders on it since the account was moved to Schwab. I haven't asked Schwab about RNVA yet, because I don't expect the trading restrictions to remain in place for long. EM is like fifty years ago when OTC literally meant the trade is placed over the counter.
The one's who can trade EM of course.
Goony is the Black Knight.
God has a buy recommendation on RNVA. RNVA doing God's work. RNVA heals.
So it's "move the price up, move the price up?"
The ticker ticked. Where's Diggity?
Somebody managed to place a buy order at 10:43.
This post for RNVA went up on Schwab today: "Certain information for this symbol is unavailable." That is accurate. All the EM, grey market talk means nothing. This is the most useful post here on the matter yesterday: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174773698
Let them babble. We know what's coming.
All guess work, but I see a NYSE AM listed Rennova Health, Inc. with wholly-owned subsidiaries Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and FOXO Technologies, Inc./Innovaqur, Inc..
INQR and the existing FOXO Technologies would obviously be more efficient under one management (by a factor of 1 for 2 in fact). Hard not to speculate on that happening either as part of the FOXO/RNVA registration(s) or in a later step.
Put a lawyers, accountants, and regulators at work sign on it. Information flood will follow. This was about the only post today worth reading: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174773698
Is that your neuroscan?
Then sell and spare us the noise.
You had never even heard of Shamus Lagan a month ago. FYI, Shamus owns or has an irrevocable proxy for a sizeable majority of RNVA voting shares. He will soon be in control of FOXO, so if you really believe what you are saying, you would be selling.
FOXO's only path to ever get a return on its patents was to trade overwhelming controlling interest to RNVA. FOXO was unsustainable and had been shopping an MA for a long time. I do my reading. It's not an either or situation. RNVA and FOXO shareholders will all own the same set of businesses.
Is it an acquisition? Is it a merger? Is it a reverse merger? I think friendly takeover is the most accurate way to characterize it.
Man, RNVA earnings are the driver. You don't understand this, or you wouldn't be speaking contrary to your own interest as a FOXO shareholder. Without RNVA, FOXO will do good to manage a OTCBB listing of it's own. RNVA is taking over FOXO dummy.
You are correct sir.
You are craping in your own lunch bucket. RNVA is saving FOXO from a delisting. What's good for RNVA shareholders is good for FOXO shareholders.
RNVA has long been undervalued, so it doesn't appear anyone listens to me. In all my posts about RNVA, I haven't been wrong about much, so I'll leave the stock price manipulation game to the likes of you.